Cliff Holloway
Medicinal Chemistry
Benitec Biopharma
Australia
Biography
Dr Cliff Holloway brings over 25 years of biopharmaceutical and healthcare related experience to Benitec, in the development and commercialisation of emerging technologies and drug products, including licensing, M&A, corporate financing, and operations management. Most recently, he was CEO and Managing Director of Sienna Cancer Diagnostics Ltd. . Prior to his role at Sienna, he held the position of Managing Director at Immune System Therapeutics Ltd. and also for Biosceptre International Ltd. and was formerly VP of Business Development at Arana Therapeutics Ltd. which was acquired by US based Cephalon Inc. (now Teva) in 2009. He is currently a director of a biotech focused seed fund, Newstar Ventures
Research Interest
Medicinal Chemistry
